Bicycle Therapeutics Statistics

Total Valuation

FRA:50BA has a market cap or net worth of EUR 421.57 million. The enterprise value is -130.79 million.

Market Cap	421.57M
Enterprise Value	-130.79M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+34.28%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	17.45
PB Ratio	0.80
P/TBV Ratio	0.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.61
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.63

Financial Position

The company has a current ratio of 10.66, with a Debt / Equity ratio of 0.01.

Current Ratio	10.66
Quick Ratio	10.33
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-1,442.89

Financial Efficiency

Return on equity (ROE) is -34.59% and return on invested capital (ROIC) is -24.72%.

Return on Equity (ROE)	-34.59%
Return on Assets (ROA)	-20.59%
Return on Invested Capital (ROIC)	-24.72%
Return on Capital Employed (ROCE)	-41.75%
Revenue Per Employee	79,191
Profits Per Employee	-700,451
Employee Count	305
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	-1.87M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-66.85%
50-Day Moving Average	6.24
200-Day Moving Average	6.77
Relative Strength Index (RSI)	48.07
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.15

Income Statement

In the last 12 months, FRA:50BA had revenue of EUR 24.15 million and -213.64 million in losses. Loss per share was -3.09.

Revenue	24.15M
Gross Profit	-179.75M
Operating Income	-247.18M
Pretax Income	-215.51M
Net Income	-213.64M
EBITDA	-241.40M
EBIT	-247.18M
Loss Per Share	-3.09

Full Income Statement

Balance Sheet

The company has 552.57 million in cash and 4.89 million in debt, giving a net cash position of 547.67 million.

Cash & Cash Equivalents	552.57M
Total Debt	4.89M
Net Cash	547.67M
Net Cash Per Share	n/a
Equity (Book Value)	527.13M
Book Value Per Share	7.61
Working Capital	570.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -204.32 million and capital expenditures -1.83 million, giving a free cash flow of -206.14 million.

Operating Cash Flow	-204.32M
Capital Expenditures	-1.83M
Free Cash Flow	-206.14M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,023.40%
Pretax Margin	-892.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:50BA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.28%
Shareholder Yield	-34.28%
Earnings Yield	-50.68%
FCF Yield	-48.90%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:50BA has an Altman Z-Score of 1.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.71
Piotroski F-Score	1